INVO Fertility, Inc. (IVF)

NASDAQ: IVF · Real-Time Price · USD
1.520
-0.250 (-14.12%)
Apr 29, 2025, 10:31 AM EDT - Market open
-14.12%
Market Cap 1.01M
Revenue (ttm) n/a
Net Income (ttm) -14.86M
Shares Out 666.06K
EPS (ttm) -45.66
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 148,168
Open 1.650
Previous Close 1.770
Day's Range 1.530 - 1.650
52-Week Range 1.720 - 2.530
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About IVF

INVO Fertility, Inc., a life science portfolio company, develops clinical stage assets to treat patients with fertility, oncology, and autoimmune diseases. The company operates in two divisions, NAYA Women’s Health and NAYA Therapeutics. Its lead product includes NY-303, a GPC3-targeted FLEX-NK bispecific antibody that is in Phase I/II clinical trials for hepatocellular carcinoma, as well as solid and pediatric tumors; and NY-338, a CD38-targeted FLEX-NK bispecific antibody for multiple myeloma and autoimmune diseases. The company also offers I... [Read more]

Founded 2007
Country United States
Stock Exchange NASDAQ
Ticker Symbol IVF
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.